Clinical Trials Browser

Alzheimer Disease × ixazomib × Plasma cell × Clear all

NCT03236792 2022-09-29

Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis

Phase 1/2 Completed

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease